Common Stock |
6 Months Ended |
|---|---|
Apr. 30, 2026 | |
| Common Stock [Abstract] | |
| COMMON STOCK | NOTE 11 – COMMON STOCK
No shares of common stock were issued during the six months ended April 30, 2026.
On March 18, 2025, 21,500 warrants to acquire 21,500 shares of common stock were exercised at an exercise price of $0.59 per share of common stock for aggregate gross proceeds of $12,685, of which $0.25 per share was paid to Arras ($5,375).
The Company incurred costs of $1,332 related to warrant exercises in the six months ended April 30, 2025. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|